Literature DB >> 19370664

Workplace interventions for preventing work disability.

Sandra H van Oostrom1, Maurice T Driessen, Henrica C W de Vet, Renée-Louise Franche, Eva Schonstein, Patrick Loisel, Willem van Mechelen, Johannes R Anema.   

Abstract

BACKGROUND: Work disability has serious consequences for all stakeholders and society. Workplace interventions are considered appropriate to facilitate return to work by reducing barriers to return to work, involving the collaboration of key stakeholders.
OBJECTIVES: To determine the effectiveness of workplace interventions compared to usual care or clinical interventions on work-related outcomes and health outcomes; and to evaluate whether the effects differ when applied to musculoskeletal disorders, mental health problems, or other health conditions. SEARCH STRATEGY: We searched the Cochrane Occupational Health Field Trials Register, CENTRAL, MEDLINE and EMBASE (EMBASE.com), and PsycINFO databases (to November 2007). SELECTION CRITERIA: We included randomized controlled trials of workplace interventions aimed at return to work for workers where absence from work because of sickness was reported as a continuous outcome. DATA COLLECTION AND ANALYSIS: Two authors independently extracted data and assessed risk of bias of the studies. Meta-analysis and qualitative analysis (using GRADE levels of evidence) were performed. MAIN
RESULTS: We included six randomized controlled trials (749 workers): three on low back pain, one on upper-extremity disorders, one on musculoskeletal disorders, and one on adjustment disorders. Five studies were rated as having low risk of bias for the sickness absence outcome. The results of this review show that there is moderate-quality evidence to support the use of workplace interventions to reduce sickness absence among workers with musculoskeletal disorders when compared to usual care. However, workplace interventions were not effective to improve health outcomes among workers with musculoskeletal disorders. The lack of studies made it impossible to investigate the effectiveness of workplace interventions among workers with mental health problems and other health conditions. A comparison of a workplace intervention with a clinical intervention, in one study only, yielded similar results for sickness absence and symptoms for workers with mental health problems. AUTHORS'
CONCLUSIONS: As a result of the few available studies, no convincing conclusions can be formulated about the effectiveness of workplace interventions on work-related outcomes and health outcomes regardless of the type of work disability. The pooled data for the musculoskeletal disorders subgroup indicated that workplace interventions are effective in the reduction of sickness absence, but they are not effective in improving health outcomes. The evidence from the subgroup analysis on musculoskeletal disorders was rated as moderate-quality evidence. Unfortunately, conclusions cannot be drawn on the effectiveness of these interventions for mental health problems and other health conditions due to a lack of studies.

Entities:  

Mesh:

Year:  2009        PMID: 19370664     DOI: 10.1002/14651858.CD006955.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  88 in total

Review 1.  Workplace-based work disability prevention interventions for workers with common mental health conditions: a review of the literature.

Authors:  Georgia Pomaki; Renée-Louise Franche; Eleanor Murray; Noushin Khushrushahi; Thomas M Lampinen
Journal:  J Occup Rehabil       Date:  2012-06

2.  Implementing the work disability prevention paradigm among therapists in Hong Kong: facilitators and barriers.

Authors:  Grace P Y Szeto; Andy S K Cheng; Edwin W C Lee; Eva Schonstein; Douglas P Gross
Journal:  J Occup Rehabil       Date:  2011-03

3.  The Effect of a Workplace-Based Early Intervention Program on Work-Related Musculoskeletal Compensation Outcomes at a Poultry Meat Processing Plant.

Authors:  Michael Donovan; Asaduzzaman Khan; Venerina Johnston
Journal:  J Occup Rehabil       Date:  2017-03

Review 4.  Physical conditioning as part of a return to work strategy to reduce sickness absence for workers with back pain.

Authors:  Frederieke G Schaafsma; Karyn Whelan; Allard J van der Beek; Ludeke C van der Es-Lambeek; Anneli Ojajärvi; Jos H Verbeek
Journal:  Cochrane Database Syst Rev       Date:  2013-08-30

5.  Work disability prevention research: current and future prospects.

Authors:  G S Pransky; P Loisel; J R Anema
Journal:  J Occup Rehabil       Date:  2011-09

6.  The practical application of theory and research for preventing work disability: a new paradigm for occupational rehabilitation services in China?

Authors:  Kátia M Costa-Black; Andy S K Cheng; Mankui Li; Patrick Loisel
Journal:  J Occup Rehabil       Date:  2011-03

7.  Cost-effectiveness of a participatory return-to-work intervention for temporary agency workers and unemployed workers sick-listed due to musculoskeletal disorders: design of a randomised controlled trial.

Authors:  Sylvia J Vermeulen; Johannes R Anema; Antonius J M Schellart; Willem van Mechelen; Allard J van der Beek
Journal:  BMC Musculoskelet Disord       Date:  2010-03-28       Impact factor: 2.362

8.  Randomised controlled trial of integrated care to reduce disability from chronic low back pain in working and private life.

Authors:  Ludeke C Lambeek; Willem van Mechelen; Dirk L Knol; Patrick Loisel; Johannes R Anema
Journal:  BMJ       Date:  2010-03-16

9.  An integrated care program to prevent work disability due to chronic low back pain: a process evaluation within a randomized controlled trial.

Authors:  Ludeke C Lambeek; Willem van Mechelen; Peter C Buijs; Patrick Loisel; Johannes R Anema
Journal:  BMC Musculoskelet Disord       Date:  2009-11-30       Impact factor: 2.362

10.  Return-to-work of sick-listed workers without an employment contract--what works?

Authors:  Sylvia J Vermeulen; Sietske J Tamminga; Antonius Jm Schellart; Jan Fekke Ybema; Johannes R Anema
Journal:  BMC Public Health       Date:  2009-07-14       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.